MTOR and cancer: As observed for the protein, the level of 4E-BP3 mRNA, but not 4E-BP1 or 2, was increased after treatment with mTOR inhibitors in the three cancer cell lines (Fig. 1c,d and Supplementary Fig. 1a,b).